Bethyl is now a part of Fortis Life Sciences. Learn more.
Bethyl Beats - The Bethyl Labs Blog

 

Featured Article:

 

Learn why HVEM is considered a tumor suppressor and how it may shape future therapies

HVEM/TNFRSF14: Cancer Therapy Target?

Contributed by Jessica J. DeWitt, Ph.D.

 

Tumor Necrosis Factor Receptor Superfamily, Member 14 (TNFRSF14) is known as the herpes entry virus mediator (HVEM) because it allows the herpes virus to enter and infect the cell. New research suggests that HVEM plays a role in activating inflammatory pathways and the anti-cancer immune response. Learn why HVEM is considered a tumor suppressor and how it may shape future therapies.

Read More...

 

 

Multiplex Articles:

 


 

Full Article Library: